AroCell: Funding secured, next step - FDA
We adjust our financial projections given a new view on pricing and market uptake for AroCell. In our update we slightly raise our Base Case to SEK 2. 5 per share and discuss the capital raise, which we believe will fund operations until FDA approval in 2021.